CT900 is a Folate Receptor–mediated Thymidylate Synthase Inhibitor in Solid Tumor Patients Physician's Weekly, 25 Nov 2022 This research was conducted because CT900 is a novel small molecule thymidylate synthase inhibitor that specifically binds to…